SequelSEC

LifeStance Health Group, Inc. LFST

Services-Health Services · CIK 0001845257 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.58B
Fiscal year ended 2026-06-30
Operating income
$78.43M
Fiscal year ended 2026-06-30
Free cash flow
$173.90M
Fiscal year ended 2026-06-30

LifeStance Health Group, Inc. (LFST) reported revenue of $1.58B and net income of $50.60M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from LifeStance Health Group, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

LifeStance Health Group, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.58B
Cost of revenueUnavailable
Gross profitUnavailable
Operating income$78.43M
Net income$50.60M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$66.99M
Income tax expense$16.39M
Diluted EPSUnavailable
Selling, general & administrative$398.86M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

LifeStance Health Group, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$225.94M
Total assets$2.18B
Current assets$377.97M
Total liabilities$704.35M
Current liabilities$274.75M
Total equity incl. NCI$1.48B
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$110.96M
Goodwill$1.30B
Long-term debt$258.99M
Accounts payable$11.05M

Cash flow

LifeStance Health Group, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$217.87M
Capital expenditures$43.96M
Investing cash flow-$53.00M
Financing cash flow-$127.85M
Net change in cash$37.01M
Stock-based compensation$69.95M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$42.36M

Derived

LifeStance Health Group, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$173.90M
Gross marginUnavailable
Operating margin4.9%
FCF margin11.0%
SBC / revenue4.4%
Current ratio1.38x
Revenue YoY growth20.4%
Net margin3.2%
R&D / revenueUnavailable
CapEx / revenue2.8%
Long-term debt / equity0.18x
Effective tax rate24.5%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LFST in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-25View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

ATPC DCGO INNV LDDD NPLY OMDA PIII PNTG PRVA SRTA USPH VSEE

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.